NEWMONT CORPORATION Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net
NEWMONT CORPORATION (NEMCL) reported Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net of $1.00 million for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-04-24.
Discontinued › Income Statement › Other Income
us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet · last filed 2015-04-24
- NEWMONT CORPORATION derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2015-03-31 was $1.00M.
- NEWMONT CORPORATION derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2012-12-31 was $0.00.
- NEWMONT CORPORATION derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2011-09-30 was -$10.00M.
- NEWMONT CORPORATION derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for fiscal 2014 was -$4.00M.
- NEWMONT CORPORATION derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for fiscal 2012 was $2.00M.
- NEWMONT CORPORATION derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for fiscal 2011 was -$17.00M.
- NEWMONT CORPORATION derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for fiscal 2010 was -$2.00M.
| Period end | Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 3 month | Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 9 month | Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 12 month |
|---|---|---|---|
| 2015-03-31 | $1.00M 10-Q · filed 2015-04-24 | ||
| 2014-12-31 | -$4.00M 10-K · filed 2015-02-20 | ||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-20 | $2.00M 10-K · filed 2015-02-20 | |
| 2012-09-30 | $2.00M 10-Q · filed 2012-11-01 | ||
| 2011-12-31 | -$17.00M 10-K · filed 2012-02-24 | ||
| 2011-09-30 | -$10.00M 10-Q · filed 2012-11-01 | -$10.00M 10-Q · filed 2012-11-01 | |
| 2010-12-31 | -$2.00M 10-K · filed 2012-02-24 | ||
| 2009-12-31 | -$6.00M 10-K · filed 2012-02-24 |